Prescription drug · ANDA
Metoprolol succinate NDC 51655-888
Metoprolol succinate 100 mg/1 · Tablet, Extended release · Oral · Northwind Health Company, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51655-888-26 | 51655088826 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-888-26)Marketed from Apr 19, 2023 | |
| 51655-888-52 | 51655088852 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-888-52)Marketed from Apr 18, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metoprolol succinate
- Generic name (nonproprietary)
- metoprolol succinate
- Active ingredients
- Metoprolol succinate — 100 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213854
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 51655-888_49740b5f-0ca7-2aa7-e063-6394a90a36e9SPL ID 49740b5f-0ca7-2aa7-e063-6394a90a36e9SPL set ID fa160cd3-4349-8e94-e053-6394a90a5887RxCUI 866412UNII TH25PD4CCB
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451655088826followed by a unit qualifier and the quantityPackage 51655-0888-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Metoprolol succinate, is a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure. ( 1.3 ) 1.1 Hypertension Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 213854
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Slate Run Pharmaceuticals, LLC | 70436-167 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Slate Run Pharmaceuticals, LLC | 70436-166 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Slate Run Pharmaceuticals, LLC | 70436-183 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Slate Run Pharmaceuticals, LLC | 70436-202 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Epic Pharma, LLC | 42806-726 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Epic Pharma, LLC | 42806-724 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Epic Pharma, LLC | 42806-725 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Epic Pharma, LLC | 42806-727 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Northwind Health Company, LLC | 51655-239 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 71335-9706 |
| Metoprolol Succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-684 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1650 |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-685 |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-686 |
| Metoprolol Succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-687 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4407 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-6260 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | ST. MARY'S MEDICAL PARK PHARMACY | 60760-993 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | ST. MARY'S MEDICAL PARK PHARMACY | 60760-994 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Northwind Health Company, LLC | 51655-919 |